Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 1910-1915

  Gu, Yiqun ^a   Liang, Xiaowei ^a,h   Wu, Weixiong ^b   Liu, Minli ^c   Song, Shuxiu ^d   Cheng, Lifa ^e   Bo, Liwei ^e   Xiong, Chengliang ^f   Wang, Xinghai ^g   Liu, Xiaozhang ^a,h   Peng, Lin ⁱ   Yao, Kangshou ^j  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b Population and Family Planning Research Institute of Guangzhou   (China)

^c Population and Family Planning Institute of Guizhou Province   (China)

^d Hebei Research Institute for Family Planning   (China)

^e Henan Institute of Population and Family Planning Research   (China)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^g Jiangsu Family Planning Research Institute   (China)

^h Sichuan Family Planning Research Institute   (China)

ⁱ Yunnan Population and Family Planning Institute   (China)

^j Zhejiang Institute of Planned Parenthood Research   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INJECTABLE CONTRACEPTIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TEA SEED OIL; TESTOSTERONE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG; VEGETABLE OIL;

ACNE; ADULT; ARTICLE; AZOOSPERMIA; BEHAVIOR; BLOOD PRESSURE; BODY WEIGHT; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIDIDYMITIS; FACE EDEMA; FEASIBILITY STUDY; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HORMONAL CONTRACEPTION; HUMAN; INJECTION SITE DISCOMFORT; KIDNEY FUNCTION; LIBIDO; LIVER FUNCTION; LOADING DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE FERTILITY; MOOD; MULTICENTER STUDY; NORMAL HUMAN; OLIGOSPERMIA; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PREGNANCY RATE; PRIORITY JOURNAL; REBOUND; SEMEN ANALYSIS; SIDE EFFECT; SPERMATOGENESIS; SPERMATOZOON DENSITY; TEA; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 66749093001     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1846     Document Type: Article

References (29)

1. Heckel NJ 1939 Production of oligospermia in a man by the use of testosterone propionate. Proc Soc Exp Biol Med 40:658-659
2. Patanelli DJ 1978 Hormonal control of male fertility. , National Institutes of Health Publication no. 78-1097. Washington, DC: US Department of Health, Education, and Welfare
3. World Health Organization Task Force for the Regulation of Male Fertility 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955-959 (Pubitemid 20349588)
4. World Health Organization Task Force for the Regulation of Male Fertility 1996 Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821-829 (Pubitemid 26096926)
5. Li MH, Guo SB, Fang RY, Zhang YP 1994 Pharmacological and clinical effects of testosterone undecanoate. New Drugs Clin Remedies (Chinese) 13:279-281
6. Chen ZD, Liu JD, Kong ZL, Huang YZ, Jiang RG, Ren FJ, Huang LM, Shen ZJ, Zhu XW, Sun GH 1991 Clinical studies on therapeutical efficacy of TU in the treatment of patients with sexual dysfunction and male infertility. J Zhejiang Med Univ (Chinese) 20:127-129
7. Partsch CJ, Weinbauer GF, Fang R, Nieschlag E 1995 Injectable testosterone undecanoate has more favorable pharmacokinetics and pharmacodynamics than testosterone enanthate. Eur J Endocrinol 132:514-519
8. Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ 1998 A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. J Androl 19:761-768 (Pubitemid 29011255)
9. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E 1997 Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82:2386-2390 (Pubitemid 27337844)
10. Nieschlag E, Buchter D, von Eckardstein S, Abshagen K, Simoni M, Behre HM 1999 Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol (Oxf) 51:757-763 (Pubitemid 30050826)
11. Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ 1999 A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 84:3642-3647 (Pubitemid 30645218)
12. Gu YQ, Wang XH, Xu D, Peng L, Cheng LF, Huang MK, Huang ZJ, Zhang GY 2003 A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 88:562-568 (Pubitemid 36207791)
13. Nieschlag E 2002 Sixth Summit Meeting on Male Contraception Consensus: recommendations for regulatory approval for male hormonal contraception. Int J Androl 25:375
14. World Health Organization 1999 WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th ed. Cambridge, UK: Cambridge University Press; 4-22
15. Trussell J 2004 Contraceptive failure in the United States. Contraception 70:89-96 (Pubitemid 38993483)
16. Kost K, Singh S, Vaughan B, Trussell J, Bankole A 2008 Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 77:10-21
17. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, Handelsman DJ 2003 Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 88:4659-4667 (Pubitemid 37357508)
18. Handelsman DJ, Farley TM, Peregoudov A, Waites GM; WHO Task Force On Methods For The Regulation Of Male Fertility 1995 Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. Fertil Steril 63:125-133
19. McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ, Meriggiola C 2004 Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. J Clin Endocrinol Metab 89:142-149 (Pubitemid 38183873)
20. Meriggiola MC, Costantino A, Bremner WJ, Morselli-Labate AM 2002 Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J Androl 23:684-690 (Pubitemid 34977525)
21. Handelsman DJ, Spaliviero JA, Simpson JM, Allan CM, Singh J 1999 Spermatogenesis without gonadotropins: maintenance has a lower testosterone threshold than initiation. Endocrinology 140:3938-3946 (Pubitemid 30647087)
22. Nieschlag E, Zitzmann M, Kamischke A 2003 Use of progestins in male contraception. Steroids 68:965-972 (Pubitemid 37532421)
23. Mommers E, Kersemaekers WM, Elliesen J, Kepers M, Apter D, Behre HM, Beynon J, Bouloux PM, Costantino A, Gerbershagen HP, Grønlund L, Heger- Mahn D, Huhtaniemi I, Koldewijn EL, Lange C, Lindenberg S, Meriggiola MC, Meuleman E, Mulders PF, Nieschlag E, Perheentupa A, Solomon A, Väisälä L, Wu FC, Zitzmann M 2008 Male hormonal contraception: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 93:2572-2580
24. Wang C 1999 Clinical studies using androgen alone for male contraceptive development. In: Rajalakshmi M, Griffin PD, eds. Male contraception: present and future. New Delhi, India: New Age International Publishers; 189-200
25. Ly LP, Liu PY, Handelsman DJ 2005 Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens. Hum Reprod 20:1733-1740 (Pubitemid 40852273)
26. Liu PY, Swerdloff RS, Anawalt BD, Anderson RA, Bremner WJ, Elliesen J, Gu YQ, Kersemaekers WM, McLachlan RI, Meriggiola MC, Nieschlag E, Sitruk- Ware R, Vogelsong K, Wang XH, Wu FC, Zitzmann M, Handelsman DJ, Wang C 2008 Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 93:1774-1783
27. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C 2006 Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 367:1412-1420
28. Wu FC, Farley TM, Peregoudov A, Waites GM; WHO Task Force on Methods for the Regulation of Male Fertility 1996 Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. Fertil Steril 65:626-636 (Pubitemid 26069123)
29. Mackey MA, Conway AJ, Handelsman DJ 1995 Tolerability of intramuscular injections of testosterone ester in oil vehicle. Hum Reprod 10:862-865